| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |